TR200003101T2 - Levosimendan ve aljinik asit içeren kararlı kompozisyonlar - Google Patents

Levosimendan ve aljinik asit içeren kararlı kompozisyonlar

Info

Publication number
TR200003101T2
TR200003101T2 TR2000/03101T TR200003101T TR200003101T2 TR 200003101 T2 TR200003101 T2 TR 200003101T2 TR 2000/03101 T TR2000/03101 T TR 2000/03101T TR 200003101 T TR200003101 T TR 200003101T TR 200003101 T2 TR200003101 T2 TR 200003101T2
Authority
TR
Turkey
Prior art keywords
alginic acid
levosimendan
compositions containing
stable compositions
containing levosimendan
Prior art date
Application number
TR2000/03101T
Other languages
English (en)
Inventor
Larma Ilkka
Backman Maarit
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of TR200003101T2 publication Critical patent/TR200003101T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Bu son bulus levosimendanin kompozisyonlardaki kararliliginin arttirilmasi için aljinik asit içeren levosimendanin farmasötik kompozisyonlari ile ilgilidir. Levosimendan kan basimina ait kalp bozuklugunun tedavisinde faydalidir.
TR2000/03101T 1998-04-23 1999-04-23 Levosimendan ve aljinik asit içeren kararlı kompozisyonlar TR200003101T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980902A FI980902A7 (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia

Publications (1)

Publication Number Publication Date
TR200003101T2 true TR200003101T2 (tr) 2001-01-22

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03101T TR200003101T2 (tr) 1998-04-23 1999-04-23 Levosimendan ve aljinik asit içeren kararlı kompozisyonlar

Country Status (32)

Country Link
US (1) US6531458B1 (tr)
EP (1) EP1079834B1 (tr)
JP (1) JP4475809B2 (tr)
KR (1) KR100590622B1 (tr)
CN (1) CN1165309C (tr)
AT (1) ATE231395T1 (tr)
AU (1) AU756338B2 (tr)
BG (1) BG64766B1 (tr)
BR (1) BR9909867A (tr)
CA (1) CA2329232C (tr)
CZ (1) CZ290911B6 (tr)
DE (1) DE69905034T2 (tr)
DK (1) DK1079834T3 (tr)
EA (1) EA002428B1 (tr)
EE (1) EE04143B1 (tr)
ES (1) ES2191426T3 (tr)
FI (1) FI980902A7 (tr)
GE (1) GEP20032942B (tr)
HR (1) HRP20000703B1 (tr)
HU (1) HUP0105446A3 (tr)
ID (1) ID26650A (tr)
IL (2) IL138950A0 (tr)
MX (1) MXPA00010368A (tr)
NO (1) NO318575B1 (tr)
NZ (1) NZ507455A (tr)
PL (1) PL192274B1 (tr)
PT (1) PT1079834E (tr)
RS (1) RS49955B (tr)
SK (1) SK284600B6 (tr)
TR (1) TR200003101T2 (tr)
WO (1) WO1999055337A1 (tr)
ZA (1) ZA200005630B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
WO2002064120A1 (fr) * 2001-02-13 2002-08-22 Taisho Pharmaceutical Co., Ltd. Preparations de gel a usage interne
CA2599575A1 (en) * 2005-03-14 2006-09-21 Orion Corporation A combination treatment for enhancing diuresis
SI3370693T1 (sl) * 2015-11-06 2020-07-31 Carinopharm Gmbh Izboljšane formulacije levosimendana za intravensko dajanje kot infuzija ali injekcija in infuzijski koncentrat
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
PT76448B (en) * 1982-04-05 1986-03-20 Merck Sharp & Dohme Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A7 (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
ID26650A (id) 2001-01-25
PL192274B1 (pl) 2006-09-29
DE69905034T2 (de) 2003-09-04
KR100590622B1 (ko) 2006-06-19
EP1079834A1 (en) 2001-03-07
IL138950A0 (en) 2001-11-25
PT1079834E (pt) 2003-04-30
NO20005312D0 (no) 2000-10-20
HUP0105446A3 (en) 2002-09-30
IL138950A (en) 2006-08-20
US6531458B1 (en) 2003-03-11
DK1079834T3 (da) 2003-04-07
BG104958A (bg) 2001-07-31
ATE231395T1 (de) 2003-02-15
EP1079834B1 (en) 2003-01-22
FI980902A7 (fi) 1999-10-24
CA2329232A1 (en) 1999-11-04
EA002428B1 (ru) 2002-04-25
YU64000A (sh) 2002-12-10
CN1298303A (zh) 2001-06-06
EE200000616A (et) 2002-06-17
SK284600B6 (sk) 2005-07-01
SK15552000A3 (sk) 2001-05-10
NO20005312L (no) 2000-11-21
BG64766B1 (bg) 2006-03-31
HRP20000703A2 (en) 2001-04-30
AU3524899A (en) 1999-11-16
KR20010072577A (ko) 2001-07-31
RS49955B (sr) 2008-09-29
CZ20003779A3 (en) 2001-05-16
CZ290911B6 (cs) 2002-11-13
NO318575B1 (no) 2005-04-11
CA2329232C (en) 2007-10-30
AU756338B2 (en) 2003-01-09
EA200001097A1 (ru) 2001-04-23
HK1031998A1 (en) 2001-07-06
WO1999055337A1 (en) 1999-11-04
BR9909867A (pt) 2000-12-19
ES2191426T3 (es) 2003-09-01
NZ507455A (en) 2002-02-01
JP2002512964A (ja) 2002-05-08
EE04143B1 (et) 2003-10-15
HRP20000703B1 (hr) 2009-11-30
JP4475809B2 (ja) 2010-06-09
FI980902A0 (fi) 1998-04-23
HUP0105446A2 (hu) 2002-07-29
ZA200005630B (en) 2002-01-14
MXPA00010368A (es) 2002-07-02
PL343722A1 (en) 2001-09-10
CN1165309C (zh) 2004-09-08
DE69905034D1 (de) 2003-02-27
GEP20032942B (en) 2003-04-25

Similar Documents

Publication Publication Date Title
FR13C0021I2 (fr) Conjugates d'exendin-4 et leur utilisation medicale
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE60325404D1 (de) Gerät zur bestimmung der dialyse-effizienz
EP2172246A3 (en) Methods for Alzheimer's disease treatment and cognitive enhancement
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE60023300D1 (de) Verwendung von cpg als adjuvans für hivimpstoff
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
CY1109013T1 (el) Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν
AR004492A1 (es) Cabello artificial para implante y procedimiento para producir el mismo
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE60018569D1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
HUP9901188A2 (hu) Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez
DE502004007836D1 (de) Haarbehandlungsmittel
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE453401T1 (de) Neuer gentherapeutischer wirkstoff zur behandlung von hämophilie b und methode für dessen herstellung
BG104958A (bg) Стабилни състави, съдържащи левосимендан и алгинова киселина
DE60042210D1 (de) Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit
HUP0001260A2 (hu) Oxidáló készítmény és alkalmazása keratinszálak festésére, tartós újraformázására vagy szőkítésére
WO2002030443A3 (en) Regulation of human skin healing